Seeing Is Believing
Currently out of the existing stock ratings of Kumaraguru Raja, 14 are a BUY (93.33%), 1 are a HOLD (6.67%).
Analyst Kumaraguru Raja works at BROOKLINE with a stock forecast success ratio of 26.19% fulfilled within 114.86 days on average.
Kumaraguru Raja’s has documented 26 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CYCC, Cyclacel Pharmaceuticals at 07-Mar-2023.
Analyst best performing recommendations are on ARCT (ARCTURUS THERAPEUTICS HOLDINGS).
The best stock recommendation documented was for VERU (VERU) at 12/11/2020. The price target of $17 was fulfilled within 60 days with a profit of $10.64 (167.3%) receiving and performance score of 27.88.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
87
$56.07 (181.28%)
1 months 12 days ago
1/2 (50%)
$49.11 (129.61%)
75
Buy
48
$17.07 (55.19%)
40
2 months 15 days ago
4/8 (50%)
$10.09 (26.62%)
195
Buy
51
$20.07 (64.89%)
51
4 months 26 days ago
14/24 (58.33%)
$25.48 (99.84%)
165
Buy
54
$23.07 (74.59%)
54
8 months 1 days ago
2/5 (40%)
$21.39 (65.59%)
548
Buy
36
9 months 9 days ago
2/2 (100%)
$15.83 (78.48%)
271
What Year was the first public recommendation made by Kumaraguru Raja?